Global Influenza Vaccine Competitive Landscape Professional Research Report 2025
Research Summary
The influenza vaccine, commonly referred to as the flu shot, is a vaccine designed to protect against influenza viruses. It typically contains inactivated or weakened forms of influenza viruses or viral proteins that stimulate the immune system to produce antibodies against the virus. These antibodies help the body recognize and fight off influenza viruses if exposed to them in the future, reducing the severity of illness, complications, and transmission of the flu. Influenza vaccines are recommended for individuals of all ages, especially those at higher risk of developing severe complications from the flu, such as young children, older adults, pregnant women, and individuals with certain medical conditions. Vaccination is typically administered annually, as the influenza virus strains can change from year to year, requiring updated vaccines to provide effective protection against circulating strains. In addition to the standard injectable flu vaccine, there are also nasal spray vaccines available for certain age groups. Vaccination against influenza is a key public health measure for preventing seasonal outbreaks and reducing the burden of influenza-related illness and mortality.
According to DIResearch's in-depth investigation and research, the global Influenza Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Influenza Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Influenza Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Influenza Vaccine Include:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Influenza Vaccine Product Segment Include:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Influenza Vaccine Product Application Include:
6 Months to 3 Years
＞ 3 Years
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Influenza Vaccine Industry PESTEL Analysis
Chapter 3: Global Influenza Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Influenza Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Influenza Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Influenza Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Influenza Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Influenza Vaccine Product by Type
- 1.2.1 Trivalent Influenza Vaccine
- 1.2.2 Quadrivalent Influenza Vaccine
- 1.3 Influenza Vaccine Product by Application
- 1.3.1 6 Months to 3 Years
- 1.3.2 ＞ 3 Years
- 1.4 Global Influenza Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Influenza Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Influenza Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Influenza Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Influenza Vaccine Industry Trends and Innovation
- 1.5.1 Influenza Vaccine Industry Trends and Innovation
- 1.5.2 Influenza Vaccine Market Drivers and Challenges
- 2 Influenza Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Influenza Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Influenza Vaccine Market Analysis by Regions
- 4.1 Influenza Vaccine Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Influenza Vaccine Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Influenza Vaccine Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Influenza Vaccine Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Influenza Vaccine Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Influenza Vaccine Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Influenza Vaccine Sales Forecast by Region (2026-2032)
- 4.4 Global Influenza Vaccine Sales Price Trend Analysis (2020-2032)
- 5 Global Influenza Vaccine Market Size by Type and Application
- 5.1 Global Influenza Vaccine Market Size by Type
- 5.1.1 Global Influenza Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Influenza Vaccine Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Influenza Vaccine Market Size by Application
- 5.2.1 Global Influenza Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Influenza Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Influenza Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Influenza Vaccine Market Size by Type
- 6.3.1 North America Influenza Vaccine Sales by Type (2020-2032)
- 6.3.2 North America Influenza Vaccine Revenue by Type (2020-2032)
- 6.4 North America Influenza Vaccine Market Size by Application
- 6.4.1 North America Influenza Vaccine Sales by Application (2020-2032)
- 6.4.2 North America Influenza Vaccine Revenue by Application (2020-2032)
- 6.5 North America Influenza Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Influenza Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Influenza Vaccine Market Size by Type
- 7.3.1 Europe Influenza Vaccine Sales by Type (2020-2032)
- 7.3.2 Europe Influenza Vaccine Revenue by Type (2020-2032)
- 7.4 Europe Influenza Vaccine Market Size by Application
- 7.4.1 Europe Influenza Vaccine Sales by Application (2020-2032)
- 7.4.2 Europe Influenza Vaccine Revenue by Application (2020-2032)
- 7.5 Europe Influenza Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Influenza Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Influenza Vaccine Market Size by Type
- 8.3.1 China Influenza Vaccine Sales by Type (2020-2032)
- 8.3.2 China Influenza Vaccine Revenue by Type (2020-2032)
- 8.4 China Influenza Vaccine Market Size by Application
- 8.4.1 China Influenza Vaccine Sales by Application (2020-2032)
- 8.4.2 China Influenza Vaccine Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Influenza Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Influenza Vaccine Market Size by Type
- 9.3.1 APAC (excl. China) Influenza Vaccine Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Influenza Vaccine Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Influenza Vaccine Market Size by Application
- 9.4.1 APAC (excl. China) Influenza Vaccine Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Influenza Vaccine Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Influenza Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Influenza Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Influenza Vaccine Market Size by Type
- 10.3.1 Latin America Influenza Vaccine Sales by Type (2020-2032)
- 10.3.2 Latin America Influenza Vaccine Revenue by Type (2020-2032)
- 10.4 Latin America Influenza Vaccine Market Size by Application
- 10.4.1 Latin America Influenza Vaccine Sales by Application (2020-2032)
- 10.4.2 Latin America Influenza Vaccine Revenue by Application (2020-2032)
- 10.5 Latin America Influenza Vaccine Market Size by Country
- 10.6 Latin America Influenza Vaccine Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Influenza Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Influenza Vaccine Market Size by Type
- 11.3.1 Middle East & Africa Influenza Vaccine Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Influenza Vaccine Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Influenza Vaccine Market Size by Application
- 11.4.1 Middle East & Africa Influenza Vaccine Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Influenza Vaccine Revenue by Application (2020-2032)
- 11.5 Middle East Influenza Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Influenza Vaccine Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Influenza Vaccine Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Influenza Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Influenza Vaccine Average Sales Price by Manufacturers (2021-2025)
- 12.2 Influenza Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Influenza Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Sanofi
- 13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Sanofi Influenza Vaccine Product Portfolio
- 13.1.3 Sanofi Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 CSL
- 13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CSL Influenza Vaccine Product Portfolio
- 13.2.3 CSL Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 GSK
- 13.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 GSK Influenza Vaccine Product Portfolio
- 13.3.3 GSK Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Viatris
- 13.4.1 Viatris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Viatris Influenza Vaccine Product Portfolio
- 13.4.3 Viatris Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 AstraZeneca
- 13.5.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 AstraZeneca Influenza Vaccine Product Portfolio
- 13.5.3 AstraZeneca Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Hualan Bio
- 13.6.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Hualan Bio Influenza Vaccine Product Portfolio
- 13.6.3 Hualan Bio Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Changchun Institute of Biological
- 13.7.1 Changchun Institute of Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Changchun Institute of Biological Influenza Vaccine Product Portfolio
- 13.7.3 Changchun Institute of Biological Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Sinovac
- 13.8.1 Sinovac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Sinovac Influenza Vaccine Product Portfolio
- 13.8.3 Sinovac Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 BCHT
- 13.9.1 BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 BCHT Influenza Vaccine Product Portfolio
- 13.9.3 BCHT Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Jiangsu GDK
- 13.10.1 Jiangsu GDK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Jiangsu GDK Influenza Vaccine Product Portfolio
- 13.10.3 Jiangsu GDK Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 KM Biologics
- 13.11.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 KM Biologics Influenza Vaccine Product Portfolio
- 13.11.3 KM Biologics Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Influenza Vaccine Industry Chain Analysis
- 14.2 Influenza Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Influenza Vaccine Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Influenza Vaccine Typical Downstream Customers
- 14.4 Influenza Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook